1Cell.Ai and BioSkryb Forge Partnership for Multi-omics Innovation
Deal News | May 08, 2025 | Anzu Partners LLC
1Cell.Ai, recognized for its expertise in single cell precision diagnostics, has formed a strategic partnership with BioSkryb Genomics, which is renowned for its advancements in single cell multi-omics. This collaboration aims to co-develop and commercialize innovative next-generation solutions in single cell multi-omics. The commercial collaboration is expected to leverage the unique strengths and expertise of both companies to drive advancements and innovation in the field of multi-omics, ultimately benefiting precision diagnostics and personalized medicine. Anzu Partners LLC, a private equity firm, is associated with the deal, indicating their investment and support in driving forward innovations in the genomic and diagnostics fields.
Sectors
- Biotechnology
- Healthcare & Diagnostics
- Private Equity
Geography
- Global – 1Cell.Ai is identified as a global leader, implying that the effects of their partnership with BioSkryb Genomics will have international significance.
Industry
- Biotechnology – The collaboration between 1Cell.Ai and BioSkryb Genomics is set in the biotechnology sector as both companies specialize in single cell multi-omics and precision diagnostics.
- Healthcare & Diagnostics – Single cell precision diagnostics and multi-omic solutions are central to innovation in healthcare and diagnostics, which are key areas for the companies involved in the partnership.
- Private Equity – Anzu Partners LLC, a private equity firm, is backing the collaboration, indicating the relevance of the private equity industry in financing innovations within the genomics sector.
Financials
Participants
| Name | Role | Type | Description |
|---|---|---|---|
| 1Cell.Ai | Participant in the strategic partnership | Company | A global leader in single cell precision diagnostics. |
| BioSkryb Genomics | Participant in the strategic partnership | Company | A pioneer in single cell multi-omics technology. |
| Anzu Partners LLC | Investor/Backer | Company | A private equity firm supporting the strategic partnership between 1Cell.Ai and BioSkryb Genomics. |